Tuesday, December 12, 2006

Vioxx Litigation Update

An article in the New York Times -- Merck Reports Progress on Overhaul, by the Associated Press -- provides an update on the Vioxx litigation:

The company provided an update on the mounting litigation over Vioxx, the former blockbuster painkiller it pulled from the market on Sept. 30, 2004 after its own research showed Vioxx doubled the risk of heart attacks and strokes. Merck said Tuesday it now faces about 27,200 personal injury lawsuits over Vioxx, representing about 45,900 plaintiff groups, plus 265 potential class action suits.

Another 14,000 plaintiffs have entered agreements with Merck suspending the time limit for lawsuits. Suits by more than 3,000 plaintiff groups have been dismissed, although about two-thirds of those may be refiled later.

So far, Merck has reserved nearly $1.6 billion for its legal defense costs but has resisted setting aside any money to pay jury awards or settlements with plaintiffs.

BGS

http://lawprofessors.typepad.com/mass_tort_litigation/2006/12/vioxx_litigatio.html

Vioxx | Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef00d8356f80f269e2

Listed below are links to weblogs that reference Vioxx Litigation Update:

Comments

I am inquiring to find out the current progression of the vioxx lawsuit. I have been informed that I quilify and have signed all of the papers and sent them to Brown and Greer
in Houston, Texas.

Sandra Lindsey b/d 05/11/1942

Posted by: Sandra Lindsey | Oct 8, 2008 8:11:21 PM

Post a comment